Pomalidomide-PEG2-OH
CAS No. 2143097-10-1
Pomalidomide-PEG2-OH ( 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]- )
产品货号. M28648 CAS No. 2143097-10-1
Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
纯度: >98% (HPLC)
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2722 | 有现货 |
|
10MG | ¥4026 | 有现货 |
|
25MG | ¥6423 | 有现货 |
|
50MG | ¥9153 | 有现货 |
|
100MG | ¥12312 | 有现货 |
|
500MG | ¥24057 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Pomalidomide-PEG2-OH
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
-
产品描述Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
-
同义词1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]-
-
通路Others
-
靶点Other Targets
-
受体CYP2C9;inflammation
-
研究领域——
-
适应症——
化学信息
-
CAS Number2143097-10-1
-
分子量361.4
-
分子式C17H19N3O6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOCCOCCNc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Arprinocide
Arprinocid is an inhibitor of hypoxanthine-guanine transport.
-
C-DIM12
C-DIM12 increased expression of transfected human Nurr1, induced Nurr1 protein expression in primary dopaminergic neurons and enhanced neuronal survival from exposure to 6-OHDA.
-
ATI-2341 TFA (133787...
ATI-2341 is an effective functionally selective allosteric agonist for the c-x-c chemokine receptor type 4 (CXCR4), which ACTS as a biased ligand in favor of G G G G G 1 activation instead of G G G G G 13.ATI-2341 activates the inhibitory heterotrimer G protein (Gi) to promote inhibition of cAMP production and induce calcium mobilization.ATI-2341 is an effective mobilization agent for myeloid polymorphonuclear neutrophils (PMNs) and hematopoietic stem and progenitor cells (HSPCs).